Literature DB >> 23563495

Computational approaches for exploring the potential synergy and polypharmacology of Duhuo Jisheng Decoction in the therapy of osteoarthritis.

Chun-Song Zheng1, Xiao-Jie Xu, Hong-Zhi Ye, Guang-Wen Wu, Xi-Hai Li, Su-Ping Huang, Xian-Xiang Liu.   

Abstract

The Duhuo Jisheng Decoction (DHJSD), a traditional Chinese medicine (TCM), has been widely used to treat osteoarthritis (OA). However, the mechanisms of action of the DHJSD have not been clearly elucidated. In the present study, the compounds in the DHJSD were characterized by three computational methods; the ligand clustering, chemical space distribution and network construction and analysis methods. The compounds that formed the medical composition of the DHJSD were divided into 10 clusters and possessed a broad diversity in chemical space distribution. The compounds also had the same coverage of chemical space as the OA drug/drug‑like compounds from DrugBank. In addition, multiple active compounds were identified as able to target multiple proteins in the drug‑target association networks (D‑T networks). A certain number of key compounds in the D‑T networks have been previously reported in the literature. The present study also constructed drug‑drug association networks (D‑D networks) and classified the DHJSD compounds into five clusters. The clusters represented multiple diverse combinations binding to the OA targets. These results suggested that the DHJSD had drug‑ and lead‑like compounds with potential synergy and polypharmacology against OA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563495     DOI: 10.3892/mmr.2013.1411

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway.

Authors:  Zong-Chao Liu; Zhen-Long Wang; Chen-Yi Huang; Zhi-Jiang Fu; Yong Liu; Zhang-Chao Wei; Shi-Gui Liu; Chuan Ma; Jie-Liang Shen; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  Deciphering the underlying mechanisms of Diesun Miaofang in traumatic injury from a systems pharmacology perspective.

Authors:  Chun-Song Zheng; Chang-Long Fu; Cai-Bin Pan; Hong-Juan Bao; Xing-Qiang Chen; Hong-Zhi Ye; Jin-Xia Ye; Guang-Wen Wu; Xi-Hai Li; Hui-Feng Xu; Xiao-Jie Xu; Xian-Xiang Liu
Journal:  Mol Med Rep       Date:  2015-04-16       Impact factor: 2.952

3.  Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model.

Authors:  Chun-Song Zheng; Yin-Sheng Wu; Hong-Juan Bao; Xiao-Jie Xu; Xing-Qiang Chen; Hong-Zhi Ye; Guang-Wen Wu; Hui-Feng Xu; Xi-Hai Li; Jia-Shou Chen; Xian-Xiang Liu
Journal:  Exp Ther Med       Date:  2014-04-02       Impact factor: 2.447

Review 4.  Evidence of Chinese herbal medicine Duhuo Jisheng decoction for knee osteoarthritis: a systematic review of randomised clinical trials.

Authors:  Wenming Zhang; Shangquan Wang; Ranxing Zhang; Yuanyuan Zhang; Xinjian Li; Yanping Lin; Xu Wei
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

5.  Efficacy and Safety of Modified Duhuo Jisheng Decoction in the Treatment of Lumbar Disc Herniation: A Systematic Review and Meta-Analysis.

Authors:  Zhencheng Xiong; Ping Yi; Liubo Zhang; Haoning Ma; Wenhao Li; Mingsheng Tan
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

6.  Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology.

Authors:  Zhencheng Xiong; Can Zheng; Yanan Chang; Kuankuan Liu; Li Shu; Chi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-05       Impact factor: 2.629

7.  Efficacy of Duhuo Jisheng Decoction in Treating Ankylosing Spondylitis: Clinical Evidence and Potential Mechanisms.

Authors:  Yi Wang; Zhihua Zhou; Li Chen; Xiangwei He; Hui Li; Yingru Huang; Yu Pu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-04       Impact factor: 2.629

8.  Computational pharmacological comparison of Salvia miltiorrhiza and Panax notoginseng used in the therapy of cardiovascular diseases.

Authors:  Chun-Song Zheng; Xiao-Jie Xu; Hong-Zhi Ye; Guang-Wen Wu; Hui-Feng Xu; Xi-Hai Li; Su-Ping Huang; Xian-Xiang Liu
Journal:  Exp Ther Med       Date:  2013-09-10       Impact factor: 2.447

9.  Understanding the diverse functions of Huatan Tongluo Fang on rheumatoid arthritis from a pharmacological perspective.

Authors:  Chunsong Zheng; Mingshan Qiu; Xiaojie Xu; Hongzhi Ye; Qian Zhang; Yihan Li; Xianxiang Liu; Jinchun Chen
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.